BlackRock Boosts Voting Power in Uniphar PLC, Signaling Confidence in Pharma Growth
BlackRock’s new voting‑right stake in Uniphar PLC boosts investor confidence, highlighting the company’s strategic growth in pharma and med‑tech.
2 minutes to read
UNIPHAR PLC
Uniphar PLC Hits 52-Week High Amid Strategic GCC Expansion and Mixed Analyst Sentiment
Uniphar PLC has reached a new 52-week high, trading at GBX 348, and is expanding its reach through a strategic agreement with Santhera Pharmaceuticals to distribute a treatment for Duchenne muscular dystrophy in the GCC region.
2 minutes to read